U.S. Clinical Microbiology Market Size & Outlook
U.S. clinical microbiology market, 2018-2030 (US$M)
Related Markets
U.S. clinical microbiology market highlights
- The U.S. clinical microbiology market generated a revenue of USD 1,626.9 million in 2023 and is expected to reach USD 2,226.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.6% from 2024 to 2030.
- In terms of segment, reagents was the largest revenue generating product in 2023.
- Laboratory Instruments is the most lucrative product segment registering the fastest growth during the forecast period.
Clinical microbiology market data book summary
| Market revenue in 2023 | USD 1,626.9 million |
| Market revenue in 2030 | USD 2,226.6 million |
| Growth rate | 4.6% (CAGR from 2023 to 2030) |
| Largest segment | Reagents |
| Fastest growing segment | Laboratory Instruments |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Laboratory Instruments, Automated Culture System, Reagents |
| Key market players worldwide | BioMerieux SA, Abbott Laboratories, BD, Danaher Corp, Hologic Inc, Roche Holding AG ADR, Bruker Corp, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.6% of the global clinical microbiology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. clinical microbiology market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 255.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Microbiology Market Scope
Clinical Microbiology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. clinical microbiology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical microbiology market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 72.2% in 2023. Horizon Databook has segmented the U.S. clinical microbiology market based on laboratory instruments, automated culture system, reagents covering the revenue growth of each sub-segment from 2018 to 2030.
U.S. accounted for the largest market share in 2015. It was mainlyattributed to higher number of testing volumes owing tohigh prevalence of infectious diseases and associated re-emergence. U.S. has witnessed increased prevalence of hospital-acquired infections.
For instance, according to the Centers for Disease Control and Prevention (CDC), around 648,000people develop hospital-acquired infections every year.
Similarly, HIV affected 1.2 million people in 2013 with 50,000 new cases registered every year. In addition, key players of the market are based in the region. Therefore, revenue generated by these players is contributing to the growth of the U.S. clinical microbiology market.
Reasons to subscribe to U.S. clinical microbiology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. clinical microbiology market databook
-
Our clientele includes a mix of clinical microbiology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. clinical microbiology market , including forecasts for subscribers. This country databook contains high-level insights into U.S. clinical microbiology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. clinical microbiology market size, by product, 2018-2030 (US$M)
U.S. Clinical Microbiology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
